Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years

Clinical trial NCT07505888 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07505888
Sponsor: Sinovac Biotech Co., Ltd
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Epidemic Meningitis Meningococcal Vaccines

Start date: 2026-03-22
Primary completion: 2026-11-01
Enrollment: 660

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.